These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4698589)

  • 1. Contraceptive use--efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days.
    Schwallie PC; Assenzo JR
    Fertil Steril; 1973 May; 24(5):331-9. PubMed ID: 4698589
    [No Abstract]   [Full Text] [Related]  

  • 2. Depo-medroxyprogesterone acetate as a contraceptive agent: its effect on weight and blood pressure.
    Leiman G
    Am J Obstet Gynecol; 1972 Sep; 114(1):97-102. PubMed ID: 4637044
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
    Jeppsson S
    Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161
    [No Abstract]   [Full Text] [Related]  

  • 4. Contraception with a six-monthly injection of progestogen. 1. Effects on blood pressure, body weight and uterine bleeding pattern, side-effects, efficacy, and acceptability.
    Mackay EV; Khoo SK; Adam RR
    Aust N Z J Obstet Gynaecol; 1971 Aug; 11(3):148-56. PubMed ID: 5286756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experiences with the use of contraceptive preparation Depo-Provera].
    Bruchác D; Sklovský A
    Cesk Gynekol; 1972 Sep; 37(7):516-7. PubMed ID: 4562178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of depot medroxy progesterone acetate as a contraceptive.
    el-Mahgoub S; Karim M; Ammar R
    Acta Obstet Gynecol Scand; 1972; 51(3):251-5. PubMed ID: 5072160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects and acceptability].
    Marker IL
    Ugeskr Laeger; 1973 Feb; 135(6):294-7. PubMed ID: 4690434
    [No Abstract]   [Full Text] [Related]  

  • 8. Use-effectiveness of six-month injections of DMPA as a contraceptive.
    McDaniel EB; Pardthaisong T
    Am J Obstet Gynecol; 1974 May; 119(2):175-80. PubMed ID: 4823385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of depo-medroxyprogesterone acetate as a contraceptive agent.
    Powell LC; Seymour RJ
    Am J Obstet Gynecol; 1971 May; 110(1):36-41. PubMed ID: 5573607
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of an injectable progestin-estrogen as a contraceptive.
    Scommegna A; Lee AW; Borushek S
    Am J Obstet Gynecol; 1970 Aug; 107(8):1147-55. PubMed ID: 4917852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular depomedroxyprogesterone acetate for contraception.
    Koetsawang S; Srisuphandit S; Srivanaboon S; Bhiraleus P; Rachawat D; Kiriwat O; Koetsawang A
    J Med Assoc Thai; 1974 Aug; 57(8):396-406. PubMed ID: 4413964
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting contraception. A brief report.
    Tipton HB
    Rocky Mt Med J; 1972 Nov; 69(11):44-5. PubMed ID: 4638612
    [No Abstract]   [Full Text] [Related]  

  • 13. Parenteral medroxyprogesterone as a contraceptive agent.
    Scutchfield FD; Long WN
    Public Health Rep (1896); 1969 Dec; 84(12):1059-62. PubMed ID: 4982071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medroxprogestrone acetate as a contraceptive].
    Hornemann B; Osler M
    Ugeskr Laeger; 1973 Feb; 135(6):289-94. PubMed ID: 4690433
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contraception with the 3-months injection].
    Hauser GA
    Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704
    [No Abstract]   [Full Text] [Related]  

  • 16. In utero medroxyprogesterone exposure after contraceptive failure.
    Brady JE; Brundage SC
    J Am Board Fam Pract; 1996; 9(4):285-8. PubMed ID: 8829079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents.
    Gerlach LS; Saldaña SN; Wang Y; Nick TG; Spigarelli MG
    Clin Ther; 2011 Feb; 33(2):182-7. PubMed ID: 21397330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a long-term contraceptive of semestral application. Preliminary report].
    Rubio Lotvin B; Ruiz Moreno JA; Bolio Arista R; González Ansorena R
    Ginecol Obstet Mex; 1973 Jun; 33(200):595-601. PubMed ID: 4732314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent].
    Linthorst G; Wibaut EP; de Jongh RE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1694-8. PubMed ID: 5069858
    [No Abstract]   [Full Text] [Related]  

  • 20. Contraception with a six-monthly injection of progestogen. 2. Effects on cervical mucus secretion and endocrine function.
    Mackay EV; Khoo SK; Adam RR
    Aust N Z J Obstet Gynaecol; 1971 Aug; 11(3):156-63. PubMed ID: 5286757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.